This award, initiated by the AUA Residents Committee and approved by the AUA Board, is presented annually to recognize an outstanding urology educator or program director who has dedicated a portion of his/her career to teaching residents and advancing urology graduate medical education.
Loretta Muss, Coordinator of the N.C. Cancer Hospital Patient and Family Advisory Board, and fellow board member, Ryan Keith, talked about cancer care & families on the February 25, 26, and 27 broadcasts of YOUR HEALTH®.
Chapel Hill, NC – In a paper published today in the journal, Cell, a team from the University of North Carolina at Chapel Hill has explained for the first time how a long-studied protein complex affects cell migration and how external cues affect cell’s ability to migrate.
UNC Lineberger patient David Alston talks about the treatment he is undergoing for testicular cancer.
The story "Men find emotional support on hospital bathroom's dry erase board" aired on February 23, 2012 on WRAL.
The story "Shortages Of Life-Saving Drugs Getting Worse" aired today on WFAE 90.7, Charlotte's NPR news source.
UNC Lineberger’s Carolina Well and the Comprehensive Cancer Support Program (CCSP) offered a workshop on “Cancer Transitions: Promoting Wellness & Group Process” for community outreach coordinators and their community partners as well for interested UNC nurses and staff.
Chapel Hill, NC – A series of 15 scientific papers published this week in the journals of the Genetics Society of America (Genetics and G3: Genes|Genomes|Genetics) put North Carolina at the epicenter of a scientific resource called the Collaborative Cross – a “library” of genetic diversity that scientists believe can help fast-track important discoveries about genetics and disease into new discoveries, tests, and treatments that impact human health.
Training the next generation of scientists is vital to continued progress in understanding cancer and all human disease. But how do students evaluate the programs offered by colleges and universities to decide which program is the best fit for them?
Making a simple substitution of water or diet soft drinks for drinks with calories can help people lose four to five pounds, a new University of North Carolina at Chapel Hill study shows.
Super Bowl Sunday was super for another reason.
A new online resource is available to help connect women and adolescents to life-saving cervical cancer-related services.
Scientists from UNC Lineberger have published a report describing an outreach program they developed for breast cancer survivors in four NC counties.
First cases in Triangle done at UNC
Lawrence Marks, MD, chair of UNC's department of radiation oncology and a UNC Lineberger member, is quoted in the article "TomoTherapy offers safer radiation" published in today's issue of The News & Observer.
Becker's Hospital Review has named the N.C Cancer Hospital as one of "70 Hospitals with Great Oncology Programs."
Bladder cancer patients in the Triangle area are not alone. They have a monthly group where “true loving support for each other” is shared, says David Langham, a bladder cancer survivor and one of the organizers of the group.
UNC and partners to study policies to restrict tobacco marketing at point of sale: multi-institutional $6.7 million research grant awarded
The way tobacco products are marketed and sold changed with the June 2009 passage of the Family Smoking Prevention and Tobacco Control Act. For example, this law mandates larger and stronger warning labels on packs and advertising and prohibits the sale of “light” and clove cigarettes. The FDA Act also now allows states and local communities to regulate the time, place, and manner of tobacco advertising. Thus, states could restrict tobacco promotions or restrict the location of tobacco advertising.
In 2008 UNC and Harvard University’s Brigham and Women’s Hospital in Boston were selected by the U.S. Agency for Healthcare Research and Quality to carry out accelerated practical studies examining the comparative effectiveness of cancer treatments. The collaboration is called the Cancer Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) Comparative Effectiveness Consortium.